Distinct patterns of cellular immune response elicited by influenza non-adjuvanted and AS03-adjuvanted monovalent H1N1(pdm09) vaccine

被引:9
作者
Giarola-Silva, Sarah [1 ]
Coelho-dos-Reis, Jordana G. A. [1 ]
Mourao, Marina Moraes [2 ]
Campi-Azevedo, Ana Carolina [1 ]
Nakagaki Silva, Erick E. [2 ]
Luiza-Silva, Maria [3 ]
Martins, Marina Angela [1 ]
de Oliveira Silveira-Cassette, Amanda Cardoso [1 ]
Batista, Mauricio Azevedo [1 ]
Peruhype-Magalhaes, Vanessa [1 ]
do Valle Antonelli, Lis Ribeiro [4 ]
Leite Ribeiro, Jose Geraldo [5 ]
Eloi-Santos, Silvana Maria [1 ,3 ]
Machado, Alexandre Vieira [6 ]
Teixeira-Carvalho, Andrea [1 ]
Martins-Filho, Olindo Assis [1 ]
Silva Araujo, Marcio Sobreira [1 ]
机构
[1] Fundacao Oswaldo Cruz FIOCRUZ Minas, Ctr Pesquisas Rene Rachou, Grp Integrado Pesquisas Biomarcadores, Belo Horizonte, MG, Brazil
[2] Fundacao Oswaldo Cruz FIOCRUZ Minas, Ctr Pesquisas Rene Rachou, Grp Helmintol & Malacol Med, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil
[4] Fundacao Oswaldo Cruz FIOCRUZ Minas, Ctr Pesquisas Rene Rachou, Biol & Imunol Parasitaria, Belo Horizonte, MG, Brazil
[5] Secretaria Estadual Saude Minas Gerais, Belo Horizonte, MG, Brazil
[6] Fundacao Oswaldo Cruz FIOCRUZ Minas, Ctr Pesquisas Rene Rachou, Imunol Doencas Virais, Belo Horizonte, MG, Brazil
关键词
H1N1; vaccine; AS03; adjuvant; Immune response; Biomarker signature; PANDEMIC H1N1 INFLUENZA; ADVERSE EVENTS; AS03; ADJUVANT; B-LYMPHOCYTES; CHILDREN; CYTOKINE; AGE; IMMUNOGENICITY; INTERLEUKIN-10; SIGNATURES;
D O I
10.1016/j.antiviral.2017.05.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The study aimed at identifying biomarkers of immune response elicited by non-adjuvanted-(NAV) and adjuvanted-(AV) H1N1(pdm09) vaccines. The results showed that despite both vaccines elicited similar levels of anti-H1N1 antibodies at day30 after vaccination, higher reactivity was observed in AV at day180. While AV induced early changes in cell-surface molecules on monocytes, CD4(+), CDS+ T-cells and B-cells, NAV triggered minor changes, starting later on at day3. Furthermore, AV induced a late and persistent increase in TLR gene expression after day3, except for tIr4, while NAV displayed earlier but transient tlr3/4/7/9 up-regulation. Contrasting with NAV, prominent chemokine gene expression (cxcl8,cxcl9,ccl5) and a broad spectrum up-regulation of plasmatic biomarkers (CXCL8,1-6,1L-1 beta,1L-12,1-10) was evident in AV, which showed a major involvement of TNF and IL-10. Similarly, AV induced a robust IL-10-modulated proinflammatory storm, with early and persistent involvement of TNF-alpha/IL-12/IFN-gamma axis derived from NK-cells, CD4(+) and CD8(+) T-cells along with promiscuous production of IL-4/IL-5/1L-13. Conversely, NAV promotes a concise and restricted intracytoplasmic chemokine/cytokine response, essentially mediated by TNF-alpha and IL-4, with late IL-10 production by CD8(+) T-cells. Systems biology approach underscored that AV guided the formation of an imbricate network characterized by a progressive increase in the number of neighborhood connections amongst innate and adaptive immunity. In AV, the early cross-talk between innate and adaptive immunity, followed by the triad NK/CD4(+)/CD8(+) T-cells at day3, sponsored a later/robust biomarker network. These findings indicate the relevance of adjuvanted vaccination to orchestrate broad, balanced and multifactorial cellular immune events that lead ultimately to a stronger H1N1 humoral immunity. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:70 / 82
页数:13
相关论文
共 50 条
[31]   A(H1N1) pdm09 influenza infection: vaccine inefficiency [J].
Friedman, Nehemya ;
Drori, Yaron ;
Pando, Rakefet ;
Glatman-Freedman, Aharona ;
Sefty, Hanna ;
Bassal, Ravit ;
Stein, Yaniv ;
Shohat, Tamy ;
Mendelson, Ella ;
Hindiyeh, Musa ;
Mandelboim, Michal .
ONCOTARGET, 2017, 8 (20) :32856-32863
[32]   Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study [J].
Nazareth, Irwin ;
Tavares, Fernanda ;
Rosillon, Dominique ;
Haguinet, Francois ;
Bauchau, Vincent .
BMJ OPEN, 2013, 3 (02)
[33]   Antibody Response After a Single Dose of an AS03-Adjuvanted Split-Virion Influenza A (H1N1) Vaccine in Heart Transplant Recipients [J].
Meyer, Sven ;
Adam, Matti ;
Schweiger, Brunhilde ;
Ilchmann, Corina ;
Eulenburg, Christine ;
Sattinger, Edgar ;
Runte, Hendrik ;
Schlueter, Michael ;
Deuse, Tobias ;
Reichenspurner, Hermann ;
Costard-Jaeckle, Angelika .
TRANSPLANTATION, 2011, 91 (09) :1031-1035
[34]   Antibody Response to Influenza A(H1N1)pdm09 Among Healthcare Personnel Receiving Trivalent Inactivated Vaccine: Effect of Prior Monovalent Inactivated Vaccine [J].
Gaglani, Manjusha ;
Spencer, Sarah ;
Ball, Sarah ;
Song, Juhee ;
Naleway, Allison ;
Henkle, Emily ;
Bozeman, Sam ;
Reynolds, Sue ;
Sessions, Wendy ;
Hancock, Kathy ;
Thompson, Mark .
JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (11) :1705-1714
[35]   Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine Two Open-label, Randomized Trials [J].
Vesikari, Timo ;
Richardus, Jan Hendrik ;
Berglund, Johan ;
Korhonen, Tiina ;
Flodmark, Carl-Erik ;
Lindstrand, Ann ;
Silfverdal, Sven Arne ;
Bambure, Vinod ;
Caplanusi, Adrian ;
Dieussaert, Ilse ;
Roy-Ghanta, Sumita ;
Vaughn, David W. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (07) :774-782
[36]   Influenza A(H1N1)pdm09 virus and asthma [J].
Obuchi, Masatsugu ;
Adachi, Yuichi ;
Takizawa, Takenori ;
Sata, Tetsutaro .
FRONTIERS IN MICROBIOLOGY, 2013, 4
[37]   Low response to a monovalent inactivated unadjuvanted influenza A (H1N1) pdm09 vaccine in pediatricians of a general hospital in Japan [J].
Hata, Atsuko ;
Mano, Chihiro ;
Nakamura, Yoshie ;
Nishida, Hitoshi ;
Kumakura, Akira ;
Mizumoto, Hiroshi ;
Yoshioka, Takakazu ;
Yoshida, Yoko ;
Shiota, Mitsutaka ;
Hata, Daisuke ;
Takahashi, Kazuo .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (05) :587-591
[38]   Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination [J].
Gefenaite, Giedre ;
Tacken, Margot ;
Bos, Jens ;
Stirbu-Wagner, Irina ;
Korevaar, Joke C. ;
Stolk, Ronald P. ;
Wolters, Bert ;
Bijl, Marc ;
Postma, Maarten J. ;
Wilschut, Jan ;
Nichol, Kristin L. ;
Hak, Eelko .
PLOS ONE, 2013, 8 (06)
[39]   Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine. [J].
Clark, Tristan W. ;
Pareek, Manish ;
Hoschler, Katja ;
Dillon, Helen ;
Nicholson, Karl G. ;
Groth, Nicola ;
Stephenson, Iain .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2424-2435
[40]   Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients [J].
Aikawa, N. E. ;
Trudes, G. ;
Campos, L. M. A. ;
Pereira, R. M. R. ;
Moraes, J. C. B. ;
Ribeiro, A. C. ;
Miraglia, J. ;
Timenetsky, M. do Carmo S. ;
Bonfa, E. ;
Silva, C. A. .
LUPUS, 2013, 22 (13) :1394-1398